192 related articles for article (PubMed ID: 23119115)
21. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
[TBL] [Abstract][Full Text] [Related]
22. Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis.
Onesti CE; Iacono D; Angelini S; Mazzotta M; Giusti R; Lauro S; Marchetti P
Anticancer Drugs; 2019 Feb; 30(2):201-204. PubMed ID: 30629552
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary adenocarcinoma with signet ring features: Detailed cytomorphologic analysis.
Vallonthaiel AG; Jain D; Madan K; Arava S
Diagn Cytopathol; 2016 Jul; 44(7):607-11. PubMed ID: 27095297
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.
Sakai Y; Nakai T; Ohbayashi C; Imagawa N; Yanagita E; Satake R; Nitta A; Kajimoto K; Sakuma T; Itoh T
Int J Surg Pathol; 2013 Oct; 21(5):476-82. PubMed ID: 23794492
[TBL] [Abstract][Full Text] [Related]
25. An unusual case of leptomeningeal carcinomatosis in a patient with primary adenocarcinoma of the lung.
Tinsley N; Yemula N; Ramalingam S; Madathil S
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29930180
[TBL] [Abstract][Full Text] [Related]
26. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
[TBL] [Abstract][Full Text] [Related]
27. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
[TBL] [Abstract][Full Text] [Related]
28. Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non-EML4-ALK rearrangements detected from cerebrospinal fluid: A case report.
Li Z; Li P; Yan B; Gao Q; Jiang X; Zhan Z; Yan Q; Lizaso A; Huang C
Thorac Cancer; 2020 Jan; 11(1):176-180. PubMed ID: 31766077
[TBL] [Abstract][Full Text] [Related]
29. ALK-positive pulmonary adenocarcinoma with signet ring features (PASRF) and polygonal cell morphology simultaneously co-expressing TTF-1/p63/P40: a case report.
Tan Y; Lu X; Li Y; Liao D; Xie W; Song J; Xue L; Zhu J
Transl Cancer Res; 2021 Aug; 10(8):3864-3869. PubMed ID: 35116685
[TBL] [Abstract][Full Text] [Related]
30. Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report.
Sabater AL; Sadaba LM; de Nova E
BMC Ophthalmol; 2012 Dec; 12():65. PubMed ID: 23249254
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.
Boland JM; Wampfler JA; Jang JS; Wang X; Erickson-Johnson MR; Oliveira AM; Yang P; Jen J; Yi ES
Am J Surg Pathol; 2014 Dec; 38(12):1681-8. PubMed ID: 25007143
[TBL] [Abstract][Full Text] [Related]
32. Syndrome of inappropriate antidiuretic hormone in a patient with leptomeningeal carcinomatosis.
Boursiquot R; Krol D; Hanif S; Rojas J; Jain M
J Med Case Rep; 2016 Mar; 10():73. PubMed ID: 27036107
[TBL] [Abstract][Full Text] [Related]
33. A case of gastric adenocarcinoma presenting as meningeal carcinomatosis.
Lee HG; Lee B; Kim SM; Suh BJ; Yu HJ
Korean J Intern Med; 2007 Dec; 22(4):304-7. PubMed ID: 18309694
[TBL] [Abstract][Full Text] [Related]
34. Leptomeningeal signet-ring cell carcinomatosis presenting with ophthalmoplegia, areflexia and ataxia.
Nakatsuji Y; Sadahiro S; Watanabe S; Fujimura H; Abe K; Koguchi K; Sakoda S
Clin Neuropathol; 2001; 20(6):272-5. PubMed ID: 11758783
[TBL] [Abstract][Full Text] [Related]
35. Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
Ko Y; Gwak HS; Park EY; Joo J; Lee YJ; Lee SH; Kwon JW; Shin SH; Yoo H
J Neurooncol; 2019 Jul; 143(3):553-562. PubMed ID: 31089925
[TBL] [Abstract][Full Text] [Related]
36. Cytological markers for predicting ALK-positive pulmonary adenocarcinoma.
Miyata K; Morita S; Dejima H; Seki N; Matsutani N; Mieno M; Kondo F; Soejima Y; Tanaka F; Sawabe M
Diagn Cytopathol; 2017 Nov; 45(11):963-970. PubMed ID: 28834601
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the Lung Metastatic to the Ovary With a Signet Ring Cell Component.
Giordano G; Cruz Viruel N; Silini EM; Nogales FF
Int J Surg Pathol; 2017 Jun; 25(4):365-367. PubMed ID: 28178894
[TBL] [Abstract][Full Text] [Related]
38. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Apr; 5(4):420-7. PubMed ID: 20130484
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous Apocrine Carcinoma With an In Situ Component and Histiocytoid and Signet-Ring Cells.
Berdugo J; Dumont-Mackay V; Brissy-Lachery S; Leclerc YE; Doyon J; Mitchell A; Petrella T; Désy D
Am J Dermatopathol; 2017 Jun; 39(6):e76-e78. PubMed ID: 28525910
[TBL] [Abstract][Full Text] [Related]
40. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
Ellis CL; Chang AG; Cimino-Mathews A; Argani P; Youssef RF; Kapur P; Montgomery EA; Epstein JI
Am J Surg Pathol; 2013 Nov; 37(11):1756-60. PubMed ID: 24061521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
